Perspective · 10 Sep 2026
Conference abstractPublished 2 Nov 2017
Chronic immuno-inflammatory diseases and applications for green tea polyphenols
UK Medical Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Millions of people worldwide suffer from chronic inflammatory diseases including periodontitis, hepatitis, pancreatitis, gastrointestinal and neurodegenerative complications which can further lead to malignancies. Inflammation and immune response are required for the tissue defense, regeneration and healing process. Yet, exaggerated and chronic inflammation can advance to life-long debilitation, loss of tissue function and organ failure. Despite the millennial advancements in diagnostic technology and therapeutic modalities, there remains no effective cure for patients who suffer from inflammatory diseases. Therefore, over 40% of patients with inflammatory complications seek some form of complementary and alternative medical (CAM) agents as adjunct therapeutic modalities, to alleviate symptoms and possibly to prevent outcomes of inflammation, whether or not to consent their clinicians. There is not sufficient scientific information or international regulatory enforcements regarding the most available CAM agents which some may interact with patientsâÂ?Â? current therapies with severe consequences. One of the most investigated agents is Green tea and it polyphenols (GrTP) with potent antioxidants effects. GrTP have important roles in regulating vital signaling pathways comprise transcription nuclear factor-kappa B mediated kappa B kinase complex pathways, programmed cell death pathways like caspases and B-cell lymphoma-2 and intervention with the surge of inflammatory markers like cytokines (e.g. TNFÃ?±, INF, IL-2, IL-6, IL-10) and production of cyclooxygenase. This workshop will explore mechanism of actions for protective effects of GrTP and some reported adverse effects. In addition, possible applications for GrTP will be presented against chronic inflammatory complications and some food safety applications.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Helieh S Oz”
